Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Send your comments and tips to

Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
 Short White Coat blogger Jennifer Srygley
Week of: November 11
Week of: November 4
Week of: October 28
Week of: October 21
Week of: October 14
Week of: October 7

« Enrollment in subsidized health plans beating projections | Main | Dana-Farber Cancer Institute gets second largest gift ever »

Wednesday, April 4, 2007

Today's Globe: hormone risk, Pembroke CEO, resistant flu, pet food, Merck drug

A 2002 study that led millions of women to throw out their hormone pills may have overestimated the dangers of that medication to women in their 50s, new research suggests. Study co-author Dr. JoAnn E. Manson will chat live with Globe readers about the report at noon at

Paul Zani, chief executive officer of Pembroke Hospital, has resigned, and the hospital has agreed to cap its admissions amid several state investigations into the private psychiatric facility.

A strain of flu has shown hints of resistance to two flu drugs among patients in a small study in Japan, a country known for prescribing the drugs more frequently than anywhere else in the world.

The Nevada firm that imported tainted wheat gluten that triggered a massive, nationwide recall of pet food said it shipped the product only to pet food manufacturers.

Merck & Co.'s arthritis drug Arcoxia, the planned successor to its withdrawn Vioxx painkiller, probably won't win US clearance because studies suggest the product raises the risks of heart attacks.

Posted by Elizabeth Cooney at 06:20 AM
Sponsored Links